Mannatech, Incorporated

MTEX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-1.8M $-586.0K $5.8M $6.5M $3.2M $-1.4M $-20.7M $-10.6M
Depreciation & Amortization $1.9M $1.9M $1.8M $1.6M $2.1M $4.8M $10.7M $11.5M
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $490.0K $690.0K $592.0K $678.0K $173.0K $209.0K $356.0K $630.0K
Net Cash from Operating Activities $10.3M $-23.0K $4.4M $9.4M $8.6M $-1.5M $-2.9M $4.0M
Investing Activities
Capital Expenditures $1.3M $2.3M $2.0M $1.5M $602.0K $379.0K $777.0K $1.8M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — $-601.0K $-268.0K $-623.0K —
Financing Activities
Dividends Paid $1.4M $672.0K $0 — — — $0 $0
Stock Repurchases $226.0K $274.0K $0 — $0 $3.0K $0 $0
Net Cash from Financing Activities — — — — $-1.6M $-1.1M $-1.2M —
Net Change in Cash $9.0M $-3.3M $4.0M $7.6M $6.0M $-3.7M $-3.5M $4.2M
Free Cash Flow $9.0M $-2.3M $2.4M $7.9M $8.0M $-1.9M $-3.7M $2.2M
← Newer Page 2 of 3 Older →